Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A One Year, Randomized, Double-Blind, Placebo-Controlled Study of TBR-760 in Adult Patients With Non-Functioning Pituitary Adenomas

NCT04335357 is registered in ClinicalTrials.gov with Tiburio Therapeutics as lead sponsor.

NCT NCT04335357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04335357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A One Year, Randomized, Double-Blind, Placebo-Controlled Study of TBR-760 in Adult Patients With Non-Functioning Pituitary Adenomas
Lead sponsor
Tiburio Therapeutics
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2020
Completion date
June 30, 2023
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non-functional pituitary adenoma, pituitary tumor, nonfunctioning